Seagen Inc.
SEC CIK 1060736 · SGEN · last insider filing 2023-12-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Baker Julian | Director | filed 2006 - 2023 |
| Baker Felix | Director | filed 2006 - 2023 |
| Baker Bros. Advisors LP | Director | filed 2012 - 2023 |
| Baker Brothers Life Sciences LP | Director | filed 2013 - 2023 |
| 667, L.P. | Director | filed 2013 - 2023 |
| Baker Bros. Advisors (GP) LLC | Director | filed 2013 - 2023 |
| Love TED W | Director | filed 2020 - 2023 |
| Gryska David W | Director | filed 2006 - 2023 |
| Welch Daniel G | Director | filed 2007 - 2023 |
| Simonian Nancy A | Director | filed 2012 - 2023 |
| Epstein David R | Director · Chief Executive Officer | filed 2022 - 2023 |
| Orwin John A | Director | filed 2014 - 2023 |
| Seth Alpna | Director | filed 2018 - 2023 |
| Swain Sandra M | Director | filed 2022 - 2023 |
| Siegall Clay B | Director · See Remarks | filed 2006 - 2022 |
| Lippman Marc E | Director | filed 2006 - 2021 |
| Akkaraju Srinivas | Director | filed 2006 - 2020 |
| Mclaughlin John Peter | Director | filed 2007 - 2016 |
| FBB3 LLC | Director | filed 2014 - 2014 |
| 14159, L.P. | Director | filed 2013 - 2014 |
| Berger Franklin M | Director | filed 2006 - 2014 |
| FBB2 LLC | Director | filed 2012 - 2012 |
| Baker Biotech Capital (GP), LLC | Director | filed 2006 - 2012 |
| Baker Bros. Capital (GP), LLC | Director | filed 2007 - 2012 |
| Baker / Tisch Capital (GP), LLC | Director | filed 2007 - 2012 |
| Baker Brothers Life Sciences Capital (GP), LLC | Director | filed 2006 - 2012 |
| 14159 Capital (GP), LLC | Director | filed 2006 - 2011 |
| Hoth Daniel Floyd JR | Director | filed 2006 - 2010 |
| JP Morgan Partners Global Investors LP | Director | filed 2006 - 2008 |
| J P Morgan Partners Global Investors Cayman LP | Director | filed 2006 - 2008 |
| Southern Douglas | Director | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Simpson Todd E | See Remarks | filed 2006 - 2023 |
| LIU Jean I | See Remarks | filed 2014 - 2023 |
| Himes Vaughn B | See Remarks | filed 2009 - 2023 |
| Dansey Roger D | See Remarks | filed 2018 - 2023 |
| Romp Charles R | EVP, Commercial U.S. | filed 2020 - 2023 |
| Taylor Robin G | Chief Commercial Officer | filed 2019 - 2019 |
| Cline Darren S | See Remarks | filed 2015 - 2018 |
| Drachman Jonathan G | See Remarks | filed 2013 - 2018 |
| Dobmeier Eric | Sr. VP, Corporate Development | filed 2006 - 2017 |
| Boerner Christopher S. | SVP, Commercial | filed 2012 - 2014 |
| Reynolds Thomas C | Chief Medical Officer | filed 2007 - 2013 |
| Rosenberg Morris | Sr. VP, Development | filed 2006 - 2012 |
| Seeley Bruce J. | EVP, Commerical | filed 2009 - 2011 |
| Trailsmith Pamela A | Chief Scientific Officer | filed 2006 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.